$201,437,825
CONSORTIUM FOR HIV/AIDS VACCINE DEVELOPMENT
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Supports HIV/AIDS vaccine research at the Scripps Research consortium; this June 2026 increment continues work begun in 2019.
Multiyear ($201M) research consortium addresses one of the most challenging vaccine-development problems; breakthrough could transform pandemic response.
Success would likely trigger vaccine manufacturing partnerships and capacity expansion with commercial pharma.
Represents sustained U.S. investment in vaccine science to maintain leadership against Chinese and global competitors.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-07-02. Cost: $0.010718.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_UM1AI144462_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.